Navigation Links
Osseon™ Therapeutics Introduces Osseoflex® BT Steerable Bone Tamp
Date:3/29/2011

SANTA ROSA, Calif., March 29, 2011 /PRNewswire/ -- Osseon® Therapeutics announced today at the Society of Interventional Radiology's (SIR) Annual Meeting the launch of the Osseoflex BT Steerable Bone Tamp.  The steerable bone tamp is designed to allow percutaneous access to sclerotic bone.  The Osseoflex BT features the same proprietary technology found in the Osseoflex® Steerable Needle and Osseoflex® DR Steerable Drill.  The Osseoflex BT articulates up to 60 degrees( and, when used in conjunction with the Osseoflex Needle, the Bone Tamp allows unipedicular access to vertebral compression fractures previously considered inaccessible due to dense, sclerotic bone or malignant tissue.  The Bone Tamp also provides clinicians with a percutaneous access option to cancellous bone in other areas of the body.

"The Osseoflex BT is the newest addition to the Osseon suite of steerable, minimally invasive devices," said John Stalcup, Ph.D., Osseon's CEO. "In the coming months, we will continue to develop and introduce complementary innovative products to address physician and patient needs."

Osseon Therapeutics currently markets the Osseoflex Steerable Needle, Osseoperm® Bone Cement, Osseoflex DR Steerable Drill, and Osseoflex Access Kit.  Together, the Osseoplasty Suite represents unparalleled products for physicians involved in the treatment vertebral compression fractures associated with osteoporosis, myelomas, and acute trauma.


'/>"/>
SOURCE Osseon Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
2. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
3. Reportlinker Adds Therapeutics for Immune System Disorders
4. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
5. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
6. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
7. Echo Therapeutics Announces 2010 Financial Results
8. Nile Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
9. Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
10. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
11. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
Breaking Medicine News(10 mins):